Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples

Cancer Science

Volumn 101, Issue 2, 2010, Pages 416-424

  Bentivegna, Angela ^a   Conconi, Donatella ^a   Panzeri, Elena ^a   Sala, Elena ^b   Bovo, Giorgio ^c   Viganò, Paolo ^d   Brunelli, Silvia ^a   Bossi, Mario ^a   Tredici, Giovanni ^a   Strada, Guido ^d   Dalprà, Leda ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b US Genetica Medica ^*  (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

^d Ospedale Bassini   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CELL MARKER; CYTOKERATIN; NESTIN; OCTAMER TRANSCRIPTION FACTOR 4;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER CARCINOMA; CANCER STEM CELL; CANCER STEM LIKE CELL; CANCER TISSUE; CANCER TRANSPLANTATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL RENEWAL; CELL STRUCTURE; CHROMOSOME; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; ANIMALS; ANTIGENS, CD; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; CHROMOSOME ABERRATIONS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASTIC STEM CELLS; PEPTIDES; URINARY BLADDER NEOPLASMS;

EID: 75649152861     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01414.x     Document Type: Article

References (32)

1. Mueller CM, Caporaso N, Greene MH. Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol 2008, 26:451-64.
2. Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 2008, 10:31-43.
3. Pardal R, Clarke MF, Morrison SJ. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 2003, 3:895-902.
4. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-7.
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-8.
6. Singh SK, Hawkins C, Clarke ID. Identification of human brain tumor initiating cells. Nature 2004, 432:396-401.
7. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007, 445:106-10.
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-5.
9. Oates JE, Grey BR, Addla SK. Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers. Stem Cells Dev 2009, 10.1089/scd.2008.0302, doi
10. She JJ, Zhang PG, Wang ZM. Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biol Ther 2008, 7:1663-8.
11. Chan KS, Espinosa I, Chao M. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. PNAS 2009, 106:14016-21.
12. Epstein JI, Amin MB, Reuter VR, Mostofi FK. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998, 22:1435-48.
13. Bidlingmaier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J Mol Med 2008, 86:1025-32.
14. Shaffer LG, Tommerup N. ISCN 2005: An International System for Human Cytogenetic Nomenclature 2005, New York, Karger
15. Osafune K, Takasato M, Kispert A, Asashima M, Nishinakamura R. Identification of multipotent progenitors in the embryonic mouse kidney by a novel colony-forming assay. Development 2006, 133:151-61.
16. Rietze RL, Reynolds BA. Neural stem cell isolation and characterization. Methods Enzymol 2006, 419:3-23.
17. Reynolds BA, Rietze RL. Neural stem cells and neurospheres - re-evaluating the relationship. Nat Methods 2005, 2:333-6.
18. Hosaka M, Hatori M, Smith R, Kokubun S. Giant cell formation through fusion of cells derived from a human giant cell tumor of tendon sheath. J Orthop Sci 2004, 9:581-4.
19. Mizrak D, Brittan M, Alison MR. CD133: molecule of the moment. J Pathol 2008, 214:3-9.
20. Corbeil D, Röper K, Hellwig A. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000, 275:5512-20.
21. Mackenzie IC. Stem cell properties and epithelial malignancies. Eur J Cancer 2006, 42:1204-12.
22. Gupta PB, Chaffer CL, Weinberg RA. Cancer stem cells: mirage or reality? Nat Med 2009, 15:1010-2.
23. Shackleton M, Quintana E, Fearon ER, Morrison SJ. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009, 138:822-9.
24. Bergman J, Reznichek RC, Rajfer J. Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings. BJU Int 2008, 101:26-9.
25. Steiner H, Bergmeister M, Verdorfer I. Early results of bladder-cancer screening in a high-risk population of heavy smokers. BJU Int 2008, 102:291-6.
26. Piccirillo SGM, Combi R, Cajola L. Distinct pools of cancer stem-like cells coexist within human glioblastomas and dislay different tumorigenicity and indipendent genomic evolution. Oncogene 2009, 28:1807-11.
27. Botchkina IL, Rowehl RA, Rivadeneira DE. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis. Cancer Genomics Proteomics 2009, 6:19-29.
28. Beier D, Hau P, Proescholdt M. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007, 67:4010-5.
29. Günther HS, Schmidt NO, Phillips HS. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008, 27:2897-909.
30. Ali MA, Sjöblom T. Molecular pathways in tumor progression: from discovery to functional understanding. Mol Biosyst 2009, 5:902-8.
31. Quintana E, Shackleton M, Sabel MS. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-8.
32. Griffero F, Daga A, Marubbi D. Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors. J Biol Chem 2009, 284:7138-48.